3m syndrome
3M Syndrome is a rare genetic disorder characterized by dwarfism, distinctive facial features, and skeletal abnormalities. The name "3M" refers to the three physicians who first described the syndrome: Miller, McKusick, and Malvaux. This condition is also known as Gloomy Face Syndrome due to the specific facial expression often associated with it. The syndrome is caused by mutations in one of three genes: CCDC8, OBSL1, or CUL7. These genes play crucial roles in the normal development and function of the skeleton and other bodily systems.
Symptoms and Characteristics[edit | edit source]
Individuals with 3M Syndrome present a variety of physical features and symptoms, including:
- Short stature, significantly below average for age and sex
- Facial features such as a prominent forehead, full cheeks, a triangular-shaped face, and a pointed chin
- Skeletal abnormalities including slender long bones and tall vertebral bodies
- Delayed bone age
- Normal intelligence and lifespan
Genetics[edit | edit source]
3M Syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. Parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene but typically do not show signs and symptoms of the condition.
Diagnosis[edit | edit source]
Diagnosis of 3M Syndrome is based on clinical evaluation and the identification of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the CCDC8, OBSL1, or CUL7 genes. Early diagnosis is crucial for the management of the condition and to provide genetic counseling for affected families.
Management[edit | edit source]
There is no cure for 3M Syndrome, but treatment is focused on managing symptoms and supporting the individual's growth and development. Growth hormone therapy may be considered to increase height, although its effectiveness varies. Orthopedic interventions may be necessary to address skeletal abnormalities. Regular follow-up with a multidisciplinary team is important to monitor growth, development, and any arising complications.
Prognosis[edit | edit source]
The prognosis for individuals with 3M Syndrome is generally good, with most leading normal lives. However, they may face challenges related to their short stature and skeletal abnormalities. Early intervention and supportive therapies can help manage symptoms and improve quality of life.
See Also[edit | edit source]
3m syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD